Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 9
1965 75
1966 132
1967 159
1968 166
1969 130
1970 156
1971 145
1972 123
1973 142
1974 136
1975 154
1976 141
1977 154
1978 152
1979 133
1980 123
1981 146
1982 141
1983 140
1984 148
1985 161
1986 165
1987 150
1988 150
1989 225
1990 200
1991 214
1992 218
1993 233
1994 290
1995 285
1996 338
1997 292
1998 331
1999 377
2000 379
2001 394
2002 514
2003 502
2004 591
2005 572
2006 647
2007 706
2008 762
2009 624
2010 700
2011 694
2012 737
2013 761
2014 668
2015 675
2016 672
2017 644
2018 635
2019 604
2020 755
2021 888
2022 818
2023 744
2024 702
2025 753
2026 570

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,029 results

Results by year

Filters applied: . Clear all
Page 1
Novel drug treatments for schizophrenia.
Coyle JT, Paul SM. Coyle JT, et al. Nat Rev Drug Discov. 2026 Apr;25(4):310-330. doi: 10.1038/s41573-025-01335-w. Epub 2026 Jan 8. Nat Rev Drug Discov. 2026. PMID: 41507454 Review.
Editorial.
Dudek D, Sobański JA, Klasa K. Dudek D, et al. Psychiatr Pol. 2026 Apr 30;60(2):167-168. doi: 10.12740/PP/222709. Epub 2026 Apr 30. Psychiatr Pol. 2026. PMID: 42391267 Free article. English, Polish.
Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases.
Schneider-Thoma J, Zhu Y, Qin M, Dong Y, Guan S, Wang J, Tian J, Lin X, Rodolico A, Siafis S, Bighelli I, Wehner M, Veith C, Krayer F, Scheuring E, Davis JM, Priller J, Nikolakopoulou A, Salanti G, Li C, Leucht S. Schneider-Thoma J, et al. Lancet. 2026 Feb 28;407(10531):876-891. doi: 10.1016/S0140-6736(25)02365-7. Lancet. 2026. PMID: 41763745 Free article.
Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.
Sass MR, Klausen MK, Schwarz CR, Rasmussen L, Giver MEB, Hviid M, Schilling C, Zamorski A, Jensen A, Gefke M, Storgaard H, Oturai PS, Kjaer A, Hartmann B, Holst JJ, Ekstrøm CT, Vinberg M, Correll CU, Vilsbøll T, Fink-Jensen A. Sass MR, et al. JAMA Psychiatry. 2026 Feb 1;83(2):128-138. doi: 10.1001/jamapsychiatry.2025.3639. JAMA Psychiatry. 2026. PMID: 41335431 Clinical Trial.
Milsaperidone: First Approval.
Shirley M. Shirley M. Clin Drug Investig. 2026 Jul;46(7):795-801. doi: 10.1007/s40261-026-01562-y. Epub 2026 May 29. Clin Drug Investig. 2026. PMID: 42213400 Review.
Schizophrenia: from mechanism to therapy.
Lu Z, Sun J, Zhao G, Zhu Y, Yuan R, Zhou J, Zhang D, Yue W. Lu Z, et al. Sci China Life Sci. 2026 Aug;69(8):2616-2639. doi: 10.1007/s11427-025-2990-0. Epub 2026 Jan 16. Sci China Life Sci. 2026. PMID: 41591612 Review.
22,029 results
You have reached the last available page of results. Please see the User Guide for more information.